- THU 05 NOV
-
14:34
Investing.com - UK
AbbVie stock hits all-time high at 298.74 USD
49 items
-
11:00
[DATA]
GuruFocus
Sector Trends: Technology Leads, Consumer Defensive Sold on Nov. 3
2 items
- WED 04 NOV
-
22:12
[DATA]
GuruFocus
AbbVie Inc (ABBV) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 77/100
2 items
-
18:59
[DATA]
GuruFocus
Nxera Pharma (SOLTF) Secures $1.5B Licensing Deal with AbbVie for IBD Therapy
-
14:42
Investing.com - news
Freedom Broker raises Abbvie stock price target on strong results
3 items
-
11:06
[DATA]
GuruFocus
What iShares Core High Dividend (HDV) Bought: Exxon Leads on Nov. 2
-
11:06
[DATA]
GuruFocus
Capital Group Cons. Equity (CGCV) Adds Microsoft and Philip Morris on Monday
-
11:05
[DATA]
GuruFocus
State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 2
2 items · also GuruFocus
-
05:05
[DATA]
GuruFocus
ABBV SWOT Analysis: Key Insights from 10-Q Filing
2 items
-
00:12
Investing.com - news
AbbVie expands Oxford R&D facility as part of £120 million-plus investment
- TUE 03 NOV CLOSE 286.00 -1.0% VOL 1.0×
-
21:30
[DATA]
GuruFocus
AbbVie Director Jennifer L. Davis Resigns Following CEO Appointment at Align Technology
- 18:43 [FILING] 10-Q sec.gov
- MON 02 NOV CLOSE 288.84 -2.1% VOL 1.7×
-
22:00
[DATA]
GuruFocus
ABBV Maintained by UBS -- Price Target Raised to $295
2 items · also GuruFocus
- 21:05 [FILING] 8-K — FORM 8-K (Item 5.02) sec.gov
-
20:32
[DATA]
GuruFocus
ABBV Maintains Outperform Rating -- Price Target Raised to $342
4 items · also GuruFocus
-
18:01
[DATA]
GuruFocus
ABBV Maintained by Morgan Stanley -- Price Target Raised to $346
5 items
-
17:49
[DATA]
GuruFocus
AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition
-
14:37
[DATA]
GuruFocus
ABBV Maintained by Wells Fargo -- Price Target Raised to $340
3 items
-
11:30
[DATA]
GuruFocus
Company Guidance Roundup: AbbVie, Dauch Raise Outlooks on Oct. 30
2 items · also GuruFocus
-
11:04
[DATA]
GuruFocus
What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29
- FRI 30 OCT CLOSE 294.89 +1.4% VOL 1.3×
- 11:51 [FILING] 8-K (Item 2.02,9.01) sec.gov
- THU 29 OCT CLOSE 290.79 +1.7% VOL 0.8×
- WED 28 OCT CLOSE 285.99 -0.1% VOL 0.6×
- TUE 27 OCT CLOSE 286.39 -0.1% VOL 0.6×
- MON 26 OCT CLOSE 286.74 +0.4% VOL 0.9×
- FRI 23 OCT CLOSE 285.64 +0.2% VOL 0.9×
- 22:04 [FILING] 3 sec.gov
- THU 22 OCT CLOSE 285.19 +0.1% VOL 1.2×
- WED 21 OCT CLOSE 284.80 -1.5% VOL 0.9×
- TUE 20 OCT CLOSE 289.08 +2.3% VOL 1.1×
- MON 19 OCT CLOSE 282.68 -1.0% VOL 0.9×
- FRI 16 OCT CLOSE 285.42 +0.7% VOL 1.2×
- THU 15 OCT CLOSE 283.40 -0.0% VOL 1.6×
- 21:00 [FILING] 8-K — FORM 8-K (Item 5.02) sec.gov
- WED 14 OCT CLOSE 283.48 +3.3% VOL 1.2×
- TUE 13 OCT CLOSE 274.36 -2.4% VOL 1.4×
- MON 12 OCT CLOSE 281.12 +1.7% VOL 1.2×
- FRI 09 OCT CLOSE 276.47 +1.5% VOL 0.9×
- THU 08 OCT CLOSE 272.42 +0.4% VOL 1.2×
- WED 07 OCT CLOSE 271.36 +1.8% VOL 1.4×
- TUE 06 OCT CLOSE 266.69 +0.3% VOL 1.0×
- MON 05 OCT CLOSE 265.76 +1.1% VOL 1.8×
- 21:07 [FILING] 8-K (Item 2.02,9.01) sec.gov
- FRI 02 OCT CLOSE 262.82 +1.1% VOL 1.4×
- THU 01 OCT CLOSE 259.93 -0.6% VOL 0.9×
- WED 30 SEPT CLOSE 261.59 -0.6% VOL 1.1×
- TUE 29 SEPT CLOSE 263.29 -1.1% VOL 1.0×
- MON 28 SEPT CLOSE 266.28 +0.7% VOL 1.1×
- FRI 25 SEPT CLOSE 264.34 -0.3% VOL 0.6×